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INCREASED radioresistance of a tumour after a number ofsublethal irradiation
doses have been administered, has been frequently reported clinically (Paterson,
1949; Cade, 1948; Windeyer, 1954). The action of the initial irradiation in
selecting the more radioresistant cells from a heterologous population, inducing
radioresistant mutants and the production of alterations in the tumour bed, have
been proposed as explanations of acquired radioresistance (Conger and Luippold,
1957).
Experimental evidence ofa direct selective or mutational effect on the tumour
cells, resulting in a condition of increased radioresistance, has been contradictory.
Irradiation lines oftransplantable animal tumours, obtained by serial irradiations
andtransplantations intofresh animals, have beenfrequentlyemployedtoevaluate
these changes. Hill, Morton and Witherbee (1919) employing mouse adenocar-
cinoma 63, Russ (1924), Mottram (1932) and Snellman (1935) on Jensen's rat
sarcoma, and more recently Dittrich, Hohne and Schubert (1956) and Lettr6
(1956) on Ehrlich mouse carcinoma have claimed positive evidence of an increase
in radioresistance. Negative evidence has been reported by Bagg (1938) on
sarcoma 180, Montgomery and Warren (1953) and Nice (1957) on transplantable
mouse lymphosarcomata, and Conger and Luippold (1957) and Baillif (1958) on
Ehrlich mouse carcinoma.
The present study was undertaken to examine the effect on radiosensitivity
of serial irradiations on transplantable mouse tumours, where the total adminis-
tered dose reached a value many times the lethal level. The experiments cited
above were conducted on well established tumours, usually ofa non strain specific
type. In this study two tumours arising in an inbred mouse strain were used as
experimental material together with a homotransplant-sarcoma 37.
MATERIALS AND METHODS
All experiments were conducted on RIII strain inbred mice. Sarcoma 37 was
chosen for study owing to the regularity of its growth rate and absence of spon-
taneous regressions. The two homologous tumours were a spindle-celled sarcoma
(BP1), induced in an inbred RIII strain mouse by subcutaneous injection of
3: 4-benzpyrene colloid and passaged 6 times before the commencement of these
experiments, and a spontaneous mammary adenocarcinoma (MV212) arising in
the same mouse strain and previously passaged 17 times. All tumours were main-
tained as subcutaneous transplants by inoculation of 1 mm.3 portions of actively
growing tumour cortex into the right flank of recipient mice by means of a trocar
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and cannula. Sarcoma 37 and the spindle-celled sarcoma BP1 were maintained
in male mice, and adenocarcinoma MV212 in females.
Establishment of Serially Irradiated Tumour Lines
Four irradiated tumour lines were established. Sarcoma 37, BP1 and MV212
received doses at each stage approaching the tumour lethal values (" B ", "F"
and " G " lines, respectively), and sarcoma 37 irradiated with a half-lethal dose
at each stage (" D " line). Subcutaneous tumours were irradiated when the ex-
ternal measurements approximated 15-30 mm.2 in area (the product of the major
and minor axes measured by calipers).
The doses administered at each stage in the irradiated series for the four
tumour lines are given in Table I. 3000 r administered to sarcoma 37 produced
tumour regression over aperiod of 15-20 days after treatment, usually to the point
at which it ceased to become palpable. If growth resumed the tumour again
became palpable within a few days. 2000 r administeredtothistumourresultedin
a slight tumour regression followed by growth cessation for a period of 12-20 days.
The homologous tumours BP1 and MV212 reacted to sublethal doses in a less
uniform manner; a cessation of growth, usually over a prolonged period, or
greatly reduced growth rate followed a small initial regression. Tumours which
became unpalpable did not recur. A proportion of tumours irradiated with doses
well below the level required for all tumours to regress exhibited complete regres-
sion. For this reason the doses administered at each stage to these two homologous
tumours were progressively reduced.
One tumour was selected at each stage, after recovery from irradiation, for
transplantation into recipient mice by subcutaneous inoculation. Tumours
developing in these mice were then irradiated and the series continued.
TABLE I.-Irradiation Doses Administered to Each Stage of the
Four Serially Irradiated Tumour Lines
Sarcoma 37 Sarcoma Adenocarcinoma
BP1 MV212
"B "line "D "line "F "line "G" line
B 0 3000r D 0 2000r .F 0 3000r .G 0 2000r
B1 ,, D1 ,, . F 1 2500r . G1 ,,
B2 ,, D2 ,, . F2 2000r . G2 1500r
B3 ,, D3 ,, . F3 1750r . G3 1250r
B4 ,, D4 ,, . F4 1500r . G4 ,,
B5 ,, D5 ,, . F5 ,, . G 5
B6 ,, D6 ,, . F6 1250r . G6 1500r
B7 ,, D7 ,, . F7 (fromF6 . G7 ,,
B8 ,, D8 ,, . + 1250r) . G8 ,,
B9 ,, D9 ,, . . G9
B10 ,, D10 (fromD9 . . G10 (fromG9
B 11 ,, + 2000r) . . + 1500r)
B 12
B 13
B 14
B 15
B 16 2500r
B 17 (from B 16
+ 2500r)
Two sources of X-irradiation were used. For the establishment of the serially
irradiated tumour lines a Siemens Stabilivolt Constant Potential Unit with a
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Siemens EW 200 water-cooled glass tube were used. X-irradiation was generated
at 190 kV and 8 mA. Filters were not employed and the dose rate in air at 25.5 cm.
from the target was 240 r/min. having a quality of0.25 mm. Cu H.V.L. Owing to
a failure in this apparatus the radiosensitivity experiments and the irradiation of
the last stages of the irradiated lines were conducted with X-ray apparatus em-
ploying a Siemens Doglas 200 kV tube maintained at the British Empire Cancer
Campaign Research Unit in Radiobiology, at the Mount Vernon Hospital.
Unfiltered radiation generated at 190 kV and 8 mA was again employed with this
apparatus. The dose rate in air at 25.5 cm. from the target was 245 r/min. having
a quality of 0.33 mm. Cu H.V.L.
Tumours were irradiated in situ, the mice being strapped to cork boards in
the prone position ventral side down. The flap of the skin to which the tumour
was adhering was lightly pulled away from the body and secured by adhesive
plaster. This procedure was adopted to minimise the effect ofscattered irradiation
on the body. A lead shield with a suitable aperture over the tumour, protected
the mouse.
External examination of the blood vessels in the skin flap, by means of a
binocular microscope, showed that the degree of tension applied did not restrict
the flow ofblood.
Radiosensitivity evaluations
To assess the radiosensitivity of control and irradiated tumour lines, the pro-
portion of "takes" of transplanted irradiated'tumour fragments was taken as a
criterion. A range ofdoses was employed up to the value where no tumours arose
from the transplantation of the irradiated fragments; this will be referred to
hereafter as the lethal level.
Thin slices, not more than 1 mm. thick, from control and irradiated line
tumours were placed on a No. 5 filter paper in a sterile 2-in. petri dish. The paper
was marked to avoid confusion of the tumour slices. A medium of 60 per cent
Earle's saline (Earle, 1943) 40 per cent horse serum was added, sufficient to cover
the tumour slices. Each dish contained collateral control and treated tumour
fragments and separate dishes were employed for each dose level. The dishes were
irradiated at room temperature at a distance of 22 cm. from the target at 190 kV
and 8 mA without filters; the dose rate in air was 342 r/min. Subsequently the
slices were cut into 1 mm. cubes and inoculated subcutaneously into the right
flanks of 12 week old mice. Twelve mice were inoculated in control and treated
groups for each dose level. These mice were kept for a period oftwo months after
irradiation; after this period animals showing no apparent external tumour were
killed and the inoculation site examined. No apparently negative mice showed
evidence of tumour establishment at autopsy.
In order to examine the possibility of the tumour bed modifying the effects
ofirradiation on control and treated tumours, in vivo irradiations with subsequent
transplantation were carried out on sarcoma 37 and its seV'ally irradiated "B"
line. In these experiments four matched tumours from er,;h group, from 50-70
sq. mm. in area, were irradiated at each dose level by the method described for
the establishment of the irradiated lines. Immediately after irradiation the
tumour cortex was excised to a depth ofabout 2 mm. from the region which faced
the X-ray tube. This material was pooled within each group and placed in a glass
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homogeniser with 4 ml. of Earle's saline. Pulping was carried out until no per-
ceptible fragments remained. This treatment had been found to give suspensions
ofsingle cells or clumps ofnot more than four cells. 0.1 ml. ofthe suspension was
inoculated subcutaneously into the right flank of 30 mice in each group. These
mice were examined over a period oftwo months for local tumour growth.
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FIG. 1.-Radiosensitivity in vitro of sarcoma 37 and its serially irradiated lines " B " (sub-lethal
dose at each stage) and " D " (half-lethal dose at each stage).
In vitro and in vivo radiosensitivity tests were conducted on sarcoma 37 and
tumours from the 12th and 17th irradiation stages of the " B " line and only
in vitro tests on the 10th stage of the " D " line. In vitro tests only were carried
out on sarcoma BP1, the 7th irradiation stage of its " F " line, adenocarcinoma
MV212 and the 10th stage of its irradiated " G " line. Owing to the restricted
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availability of the irradiation source and supply of mice, tumours from untreated
sub-line passages from the specified irradliation stages had to be used for these
tests.
RESULTS
Fig. 1 illustrates the results from in vitro radiosensitivity tests on sarcoma 37,
its derived " B " line tumours at the 12th and 17th irradiation stages (B 12 and
B 17) and the 10th irradiation stage of the " D " line (D 10).
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FIG. 2.-Radiosensitivity in vivo of sarcoma 37 and its serially irradiated " B " line.
B 12 tumours appeared to be more radiosensitive than the controls up to
2750 r. The lethal dose however was of the same order-3250 r (only one control
tumour recurred at this dose level). B 17 tumours followed the same general
pattern until the lethal dose was approached; an apparent increase in radio-
resistance at 3250 r and 3500 r may be significant. Comparable results were
obtained in the in vivo irradiation tests (Fig. 2) and B 12 tumours again exhibited
an increase in radiosensitivity over the intermediate dose range of 1500-2500 r.
Increased radioresistance in " D " line tumours was observed over the inter-
mediate dose range (Fig. 1) but again the lethal level was comparable with the
controls.
The results of in vitro radiosensitivity tests on the two homologous tumoure
and their irradiated lines were comparable (Fig. 3 and 4). An increase in radio-.
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resistance was apparent in both irradiated lines with intermediate doses. At dose
levels approaching the lethal values the response in control and treated groups
was similar; the lethal dose was the same for sarcoma BP1 and its irradiated
"F" line and varied by only 250 r between adenocarcinoma MV212 and its
irradiated " G " line.
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FIG. 3.-Radiosensitivity in vitro of sarcoma BPI1 and its serially irradiated "F "line.
DISCUSSION
Two features emerge from these experimental findings. Firstly, the lethal dose
levels of the irradiated tumour lines were not markedly different from their
respective controls. Secondly, apparent differences in radiosensitivity were
restricted to intermediate doses. Since the clinical observation ofacquired radio-
resistance is related to complete tumour destruction, experimental comparisons
should be made at this level. It would appear therefore from these experiments
that the hypothesis of a selection by previous irradiations of more radioresistant
cells, or a mutagenic effect, does not necessarily hold true. If the clinical evalua-
tion ofacquired radioresistance is based on experience ofcurability, with tumoursRADIOSENSITIVITY OF MOUSE TUMOURS 483
of comparable position and histological pattern, a degree of uniformity in radio-
sensitivity would be presupposed. However, many authors have described wide
variations in radiosensitivity among tumours of similar histological pattern, both
in the clinical and experimental fields (Smithers, 1946; Cramer, 1934; Tansley
and Wilson, 1947; Cohen and Cohen, 1955). Cathie (1939) from clinicalexperience
did not regard histology as a good gaide to sensitivity and a similar observation
was made by Goldfeder (1947) on experimental material.
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FIG. 4.-Radiosensitivity in vitro of adenocarcinoma MV212 and its serially irradiated
"G" line.
The radiosensitivity comparisons between the control and irradiated lines
indicate that a difference in response in the region of a tumour LD50 dose cannot
be extrapolated to provide information in the region of the lethal dose. The
apparent increase in radioresistance in the irradiated lines of the two homologous
tumours was observed only with intermediate doses. This effect may have been
due to a synergistic effect of an independent factor, acting against the establish-
ment of the tumour cells in the recipient host. The intensity of this factor may
have been low, so that its action might be masked at the higher irradiation doses.
This hypothetical factor may have been an immunity response by the host to the484 A. E. G. PEARSON
tumour implant. The previous irradiations might have modified the tumour cells
with respect to their ability to produce antigens, or their reaction to the host
antibodies. Cohen and Cohen (1953, 1954 a, b and c) have studied the relation
between the host immunity response to a transplantable tumour and its radio-
sensitivity; they considered that sensitivity was a function ofthe host resistance.
If acquired radioresistance in clinical practice is a veridical phenomenon, it is
suggested that immunological considerations may be involved in these isologous
instances.
SUMMARY
1. A method of establishing serially irradiated tumour lines of sarcoma 37
and two homologous tumours in an inbred mouse strain is described.
2. Radiosensitivity comparisons between the irradiated and control tumour
lines have been made.
3. No marked differences in the lethal dose were observed between the four
irradiated tumour lines and their respective controls.
4. Radiosensitivity differences were observed at intermediate dose levels.
This was regularly consistent in the irradiated lines ofthe two homologous tumours
and took the form of an increase in radioresistance.
5. The experimental results are discussed in relation to the problem ofacquired
radioresistance.
6. A possible relationship between these results and immunological factors is
suggested.
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